High Residual Collagen-Induced Platelet Reactivity Predicts Development of Restenosis in the Superficial Femoral Artery After Percutaneous Transluminal Angioplasty in Claudicant Patients

CardioVascular and Interventional Radiology

Volumn 39, Issue 2, 2016, Pages 190-194

  Gary, Thomas ^a   Prüller, Florian ^a   Raggam, Reinhard ^a   Mahla, Elisabeth ^a   Eller, Philipp ^a   Hafner, Franz ^a   Brodmann, Marianne ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COLLAGEN; ANTITHROMBOCYTIC AGENT;

AGED; ANGIOGRAPHY; ARTERIAL BLOOD; ARTICLE; BLOOD COLLECTION TUBE; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLATELET REACTIVITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; RESTENOSIS; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY RESTENOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANGIOPLASTY; DIAGNOSTIC IMAGING; FEMORAL ARTERY; HEMODYNAMICS; INTERMITTENT CLAUDICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RECURRENT DISEASE; RISK FACTOR; THROMBOCYTE;

AGED; ANGIOGRAPHY; ANGIOPLASTY; ASPIRIN; BLOOD PLATELETS; COLLAGEN; FEMALE; FEMORAL ARTERY; HEMODYNAMICS; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84957848407     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-015-1172-6     Document Type: Article

References (15)

1. Breet NJ, van Werkum JW, Bouman HJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA. 2010;303(8):754–62.
2. Chirumamilla AP, Maehara A, Mintz GS, et al. High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging. 2012;5(5):540–9.
3. Cvirn G, Hoerl G, Schlagenhauf A, et al. Stent implantation in the superficial femoral artery: short thromboelastometry-derived coagulation times identify patients with late in-stent restenosis. Thromb Res. 2012;130(3):485–90.
4. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Investig. 2005;115(12):3378–84.
5. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9(1):61–7.
6. Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost. 2007;5(Suppl 1):203–11.
7. Maurice P, Pires V, Amant C, et al. Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse. Vasc Pharmacol. 2006;44(1):42–9.
8. Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. J Vasc Surg. 2008;47(2):461–9.
9. Plenz GA, Deng MC, Robenek H, Volker W. Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis. 2003;166(1):1–11.
10. Saelman EU, Horton LF, Barnes MJ, et al. Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions. Blood. 1993;82(10):3029–33.
11. Shah B, Sedlis SP, Mai X, et al. Comparison of platelet activity measurements by use of arterial and venous blood sampling. J Thromb Haemost. 2013;11(10):1922–4.
12. Trenk D, Stone GW, Gawaz M, et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study. J Am Coll Cardiol. 2012;59(24):2159–64.
13. Wang WJ, Shih CH, Huang TF. Primary structure and antiplatelet mechanism of a snake venom metalloproteinase, acurhagin, from Agkistrodon acutus venom. Biochimie. 2005;87(12):1065–77.
14. Xu G, Ulrichts H, Vauterin S, et al. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Toxicon. 2005;45(5):561–70.
15. Zhu J, Cole F, Woo-Rasberry V, Fang XR, Chiang TM. Type I and type III collagen-platelet interaction: inhibition by type specific receptor peptides. Thromb Res. 2007;119(1):111–9.